RF179

N/A

Report date: 2025/07/07 16:51:25
NME

Base Information

Drug NameRF179
Drug Alias NameRF179RF-179
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionComplement factor B inhibitors
TargetsComplement factor B
Therapy Area/IndicationsGlomerulonephritis, IGA
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesRuifu Pharmaceutical Technology (Guangzhou) Co., Ltd.
China Registration ClassN/A

Develop Information

Active CompaniesRuifu Pharmaceutical Technology (Guangzhou) Co., Ltd.
Inactive CompaniesN/A
Active IndicationsGlomerulonephritis, IGA
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A